Cargando…
Leflunomide/methotrexate: Visceral leishmaniasis and SARS-CoV-2 infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073428/ http://dx.doi.org/10.1007/s40278-022-14665-9 |
Ejemplares similares
-
Leflunomide/rituximab: SARS-CoV-2 infection: case report
Publicado: (2021) -
Mucosal Relapse of Visceral Leishmaniasis in a Child with SARS-CoV-2 Infection
por: Colomba, Claudia, et al.
Publicado: (2023) -
Methotrexate/methylprednisolone/prednisone: Prolonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
Publicado: (2020) -
Methotrexate/mycophenolate-mofetil: SARS-CoV-2 infection: 3 case reports
Publicado: (2021) -
Thrombotic microangiopathy and liver toxicity due to a combination therapy of leflunomide and methotrexate: a case report
por: Pliquett, Rainer Ullrich, et al.
Publicado: (2020)